Neumora Therapeutics, Inc. Common Stock (NMRA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q4'20 |
|---|
| Cash from Operations | -46.4M | -47.95M | -46.63M | -52.4M | -59.45M | -50.34M | -33.48M | -56.16M | -42.95M | -51.44M | -47.77M | -31.02M | -33.04M | -30.37M | -26.58M | -32.19M | -29.35M | -17.26M | -16.51M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 21.94% | 4.74% | -39.27% | 6.68% | -38.4% | 2.14% | 29.91% | -81.03% | -30.01% | -69.41% | - | -16.71% | -2.66% | -3.45% | - | - | -77.76% | - | - |
| Net Income | -53.46M | -59.45M | -56.76M | -52.73M | -67.99M | -58.82M | -72.55M | -58.7M | -53.72M | -108.73M | -53.03M | -38.54M | -35.63M | -28.15M | -30.37M | -43.04M | -26.97M | -178.03M | -20M |
| Depreciation & Amortization | 8K | 9K | 23K | 19K | 157K | 157K | 156K | 160K | 158K | 166K | 173K | 991K | 158K | 147K | 479K | 147K | 131K | 150K | 63K |
| Stock-Based Compensation | 7.41M | 7.41M | 5.98M | 7.17M | 9.32M | 9.9M | 9.95M | 12.77M | 7.37M | 6.05M | 6.45M | 0 | 2.19M | 2.79M | 0 | 1.65M | 1.22M | 1.19M | 824K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 220K |
| Other Non-Cash Items | 406K | 870K | -364K | 747K | -412K | -225K | -472K | -1.35M | -356K | 64.18M | -177K | 1.43M | -6.09M | 18K | 1.58M | 13.11M | 750K | 157.18M | 4.65M |
| Working Capital Changes | -765K | 3.21M | 4.48M | -7.6M | -525K | -1.36M | 29.43M | -9.03M | 3.59M | -13.11M | -1.19M | 5.1M | 6.32M | -5.18M | 1.73M | -4.06M | -4.48M | 2.25M | -2.27M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 1.68M | 2.83M | -96K | -408K | -2.25M | -2.9M | 5.03M | -410K | 1.16M | -1.91M | 306K | 7.04M | 0 | -3.11M | 1.27M | -13K | -869K | -234K | -1.55M |
| Cash from Investing | 71K | 42.65M | 51.32M | 30.4M | 44.16M | -98.8M | 156.99M | 21.25M | -150M | 13.68M | 23.82M | 24.08M | 2.82M | -8.03M | -91.07M | -85.61M | -188K | -547K | -310K |
| Capital Expenditures | 0 | 16K | 0 | 0 | 0 | 0 | 0 | 0 | -775K | -4.63M | -37K | 0 | -36K | -23K | -182K | -176K | -188K | -217K | -1.3M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 71K | 0 | 0 | 84K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 184K | 71K | 896K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.85M | 0 | 0 | -13M | 0 | -330K | 990K |
| Cash from Financing | 10.88M | 58.77M | -136K | 18.46M | 0 | 15.57M | 1.53M | 2.65M | 1.84M | -481K | 232.02M | 292K | 101K | 26.83M | 2.08M | -351K | -358K | 291.99M | 11.8M |
| Debt Issued (Net) | 0 | 38.9M | -136K | 18.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 10.88M | 216K | 0 | 59K | 0 | 13.69M | 0 | 2.65M | 1.84M | -481K | 0 | 292K | -491K | 24.97M | 2.08M | 0 | -63K | 0 | 11.8M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -491K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 19.65M | 0 | 0 | 0 | 1.88M | 1.53M | 0 | 0 | 0 | 232.02M | 0 | 592K | 1.86M | 0 | -351K | -295K | 291.99M | 0 |
| Net Change in Cash | -35.46M | 53.46M | 4.55M | -3.55M | -15.29M | -133.57M | 125.04M | -32.25M | -191.11M | -38.25M | 208.07M | -6.65M | -30.12M | -11.56M | -291.23M | -118.14M | -29.9M | 274.18M | -5.02M |
| Free Cash Flow | -46.4M | -47.94M | -46.65M | -52.4M | -59.45M | -50.34M | -33.48M | -56.16M | -42.95M | -51.49M | -47.81M | -31.02M | -33.08M | -30.39M | -26.76M | -32.36M | -29.54M | -17.47M | -17.81M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 21.94% | 4.77% | -39.32% | 6.68% | -38.4% | 2.23% | 29.97% | -81.03% | -29.86% | -69.42% | - | -15.92% | -2.21% | -2.87% | - | - | -65.84% | - | - |
| FCF per Share | -0.26 | -0.29 | -0.29 | -0.32 | -0.37 | -0.31 | -0.21 | -0.35 | -0.27 | -0.32 | -0.31 | -0.20 | -0.22 | -0.20 | -0.18 | -0.21 | -0.19 | -0.11 | -0.12 |
| FCF Conversion (FCF/Net Income) | 0.87x | 0.81x | 0.82x | 0.99x | 0.87x | 0.86x | 0.46x | 0.96x | 0.80x | 0.47x | 0.90x | 0.80x | 0.93x | 1.08x | 0.88x | 0.75x | 1.09x | 0.10x | 0.83x |
| Interest Paid | 0 | 833K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 323K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |